A newly discovered gene variant makes some people naturally smoke significantly less, suggesting addiction isn't purely about willpower but has biological roots. The research sequenced nearly 38,000 smokers' genomes across multiple populations, validating findings in European and Asian ancestry groups for broader applicability.
Clarin
· Feb 25, 2026
· health
· 6 min read
High
Sourcing: Verified
Scientists identify genetic variants that reduce cigarette addiction severity
Tobacco addiction affects millions globally, contributing to 7 million annual deaths and major cardiovascular, respiratory, and cancer risks.
◉
Technology
2554 related articles
Usuarios de PayPal pueden obtener un año gratis de Perplexity Pro
LA RAZÓN · 99% match
Los 'Siete Magníficos' asiáticos: TSMC, Samsung y compañía dominan mer…
Expansión · 99% match
Anthropic presenta Claude Opus 4.7 con mejoras sustanciales en ingenie…
Digital Trends Español · 99% match
¿Sobrevivirá el teléfono inteligente a la era de la inteligencia artif…
Diario Gestión · 99% match
MANGOS: el nuevo acrónimo de Wall Street que arrasa en la inversión en…
El Economista · 99% match
Related Coverage
El Ecosistema Startup · Aug 22
Cigna invierte US$100M en IA para automatizar farmacias specialty en medio de presión regulatoria
Cigna lanza Pharmacy Forward, un programa de farmacia specialty impulsado por IA con inversión de US$100 millones hasta …
El Ecosistema Startup · Aug 22 El 98% ve al SO como pieza clave para asegurar la cadena de suministro open sourceInforme de Canonical revela que el 98% considera el SO clave para seguridad open source, pero la fragmentación de herram…
El Ecosistema Startup · Aug 22 Pew: 35% del contenido web nuevo ya está escrito por IAPew Research Center revela que 35% de las páginas web publicadas desde noviembre de 2022 muestran señales claras de auto…
DPL News · Aug 22 Telefónica renueva su Plan de Acción Climática con metas hacia cero emisiones en 2040Telefónica refuerza su compromiso ambiental con un renovado Plan de Acción Climática 2026 que busca alcanzar cero emisio…
Bias & Framing
⚖
Article presents genetic research on smoking addiction with balanced scientific framing, though emphasizes hope for treatment while downplaying current limitations of findings.
Bias Direction
center-left
Confidence
MED
Scientific optimism framing combined with public health concern emphasis. The article frames genetic discovery as offering 'hope' and 'therapeutic promise' while contextualizing smoking as a major health crisis (7 million deaths annually). Uses rhetorical questions to engage readers and establish the research's relevance.
problemática de salud pesada y difícil de enfrentar
interrogante interesante
novedoso hallazgo genético
abre una esperanza
creativas pero polémicas formas para ingerir nicotina
Tobacco industry or harm reduction advocates' perspectives on genetic research
Skeptical scientific voices questioning the practical applicability of findings
Economic/accessibility concerns about future pharmacological treatments
Perspectives from individuals with genetic variants discussed in research
Ethical implications of genetic predisposition framing for addiction
Geopolitical Impact
🌎
Genetic discovery of CHRNB3 variants reducing smoking addiction severity has minimal geopolitical implications but could shift global public health priorities and pharmaceutical development strategies.
Escalation Risk
low
Confidence
LOW
Global
United States
Denmark
Low and middle-income countries with high smoking rates
Scientific collaboration between US and Danish researchers reinforces transatlantic research partnerships. Future pharmaceutical development could shift competitive advantage to nations investing in genetic medicine and smoking cessation treatments. WHO's public health agenda may gain new therapeutic tools, potentially reducing tobacco industry influence in developing nations.
Similar to the shift from tobacco industry dominance to public health frameworks following the 1998 Master Settlement Agreement, genetic therapies could further marginalize tobacco's role in society.
Economic Lens
📈
Genetic variants in CHRNB3 gene reduce cigarette addiction severity by 21-78%, potentially enabling future pharmaceutical treatments and reducing healthcare burden from tobacco-related diseases.
Market Signal
mixed
Confidence
MED
Pharmaceutical and biotechnology
Healthcare and medical services
Tobacco industry
Public health and insurance
Consumers may benefit from future smoking cessation treatments, reducing healthcare costs and improving quality of life. However, pharmaceutical development timelines are lengthy, limiting near-term consumer access. Tobacco users with genetic predisposition could face higher insurance premiums if genetic testing becomes standard.
Governments may accelerate drug approval pathways for smoking cessation therapies. Public health agencies could implement genetic screening programs. Tobacco taxation and regulation may intensify given therapeutic alternatives. Insurance companies may adjust coverage policies based on genetic risk profiles, raising privacy and discrimination concerns.